Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

REDUCER-I: An Observational Study of the Neovasc Reducer™ System

NCT: NCT02710435 · ACTIVE_NOT_RECRUITING

NCT IDNCT02710435
StatusACTIVE_NOT_RECRUITING
Start Date2016-03
Completion2028-12

Brief Summary

The purpose of this study is to collect long term data of the Reducer System in subjects with refractory angina pectoris.

Frequently Asked Questions

What is REDUCER-I: An Observational Study of the Neovasc Reducer™ System?

REDUCER-I: An Observational Study of the Neovasc Reducer™ System is a clinical trial registered under NCT02710435. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02710435?

The current status of NCT02710435 (REDUCER-I: An Observational Study of the Neovasc Reducer™ System) is: ACTIVE_NOT_RECRUITING.

When did REDUCER-I: An Observational Study of the Neovasc Reducer™ System start?

REDUCER-I: An Observational Study of the Neovasc Reducer™ System started on 2016-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑